Rick E. Winningham, Director at Jazz Pharmaceuticals plc (JAZZ), sold 27,500 shares at $140.00 ($3.9M) on 2014-04-17, disclosed to the SEC on 2014-04-21.
Scheduled sale ($3.9M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| JAZZ | SELL | 2023-08-15 | $343K | — | Filing → |
| TBPH | SELL | 2022-12-16 | $560K | — | Filing → |
| JAZZ | SELL | 2022-08-09 | $332K | — | Filing → |